Mark S Gebert

Title: Mark S Gebert: Innovator in Pharmaceutical Excipients

Introduction

Mark S Gebert is a notable inventor based in East Palo Alto, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of improved excipients for drug formulations. His innovative work has the potential to enhance the effectiveness of pharmaceutical compositions.

Latest Patents

Mark S Gebert holds a patent for "Purified galactomannan as an improved pharmaceutical excipient." This patent discloses a substantially anhydrous, powdered galactomannan composition. The composition consists of a galactomannan hydrocolloid with about 50% to about 90% by weight of anhydromannose residues and about 10% to about 50% by weight of anhydrogalactose residues. It contains less than about 1% by weight of protein material and less than about 3% of other nonaqueous impurities. This material is particularly useful for preparing pharmaceutical compositions in both substantially anhydrous and hydrated forms. The invention aims to deliver therapeutically effective drugs to the colon while minimizing release in the upper gastrointestinal tract.

Career Highlights

Mark S Gebert is associated with Venture Lending, a division of Cupertino National Bank. His work in this capacity has allowed him to focus on innovative solutions in the pharmaceutical industry. His patent reflects his commitment to improving drug delivery systems and enhancing patient outcomes.

Collaborations

Mark has collaborated with notable colleagues, including David R Friend and David Wong. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Mark S Gebert's contributions to pharmaceutical excipients demonstrate his innovative spirit and dedication to improving drug formulations. His work has the potential to significantly impact the pharmaceutical industry and enhance therapeutic efficacy.